GI
MDGL icon

GAMMA Investing’s Madrigal Pharmaceuticals MDGL Stock Holding History

GAMMA Investing’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.4K Buy
172
+45
+35% +$23.1K ﹤0.01% 1868
2026
Q1 		$66.5K Sell
127
-11
-8% -$5.25K ﹤0.01% 1978
2025
Q4 		$80.4K Buy
138
+48
+53% +$24.5K ﹤0.01% 1734
2025
Q3 		$41.3K Buy
90
+48
+114% +$17.9K ﹤0.01% 2119
2025
Q2 		$12.7K Sell
42
-76
-64% -$22.6K ﹤0.01% 2684
2025
Q1 		$39.1K Buy
118
+67
+131% +$22K ﹤0.01% 1967
2024
Q4 		$15.7K Buy
51
+25
+96% +$7.03K ﹤0.01% 2386
2024
Q3 		$5.52K Buy
26
+14
+117% +$3.58K ﹤0.01% 2710
2024
Q2 		$3.36K Hold
12
– – ﹤0.01% 2714
2024
Q1 		$3.2K Buy
12
+4
+50% +$942 ﹤0.01% 2581
2023
Q4 		$1.73K Buy
+8
New +$1.4K ﹤0.01% 2617

Other funds holding MDGL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
SAM
Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GAMMA Investing's MDGL Position: Q2 2026 in Review

GAMMA Investing increased its Madrigal Pharmaceuticals (MDGL) stake by 35% in Q2 2026, buying an estimated $23.1K and bringing the position to 172 shares worth $92.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1868.

GAMMA Investing first reported a position in MDGL in Q4 2023 and has held it in 11 quarters since. 34 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • GAMMA Investing held 172 shares of Madrigal Pharmaceuticals worth $92.4K as of Q2 2026.
  • GAMMA Investing bought 45 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $23.1K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1868 holding.
  • GAMMA Investing first reported a position in Madrigal Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 34 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.